Tracon Pharmaceuticals, Inc.
USPTO PatentsView assignee record - 7 granted patents across 4 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Tracon ranks #38,008 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 4 technology areas.
- #38,008
- of 49,997 US assignees by volume
- 29th percentile
- by Innovation Score (28.9/100)
- 24.4
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R38008 · US Corporation #38,008 · 7 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 7 grants
- LOWER-Q #38,008/49,997
- PHOTO-FINISH Touchfire
- CPC-NARROW C07K · 4 areas
- INNOV-THIN 28.9/100
- CLAIMS-DENSE 24.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Touchfire, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Tracon’s 28.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Tracon
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Tracon Pharmaceuticals · this assignee 29
Tracon Pharmaceuticals · this assignee
29 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Tracon's Innovation Score is 28.9/100 (29th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Tracon?
Each dot is one of Tracon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tracon’s own 24.4 claims/patent is ABOVE the 11.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Tracon's grants concentrate
Tracon Pharmaceuticals, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2015. By volume, Tracon sits between Touchfire, Inc. and Tramontina USA, Inc..
Who files at Tracon's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Touchfire
Touchfire, Inc.
7 patents
- Touchlight IP
Touchlight IP Limited
7 patents
- Touchstone Resear…
Touchstone Research Laboratory Ltd.
7 patents
- Toyko Electron
Toyko Electron Limited
7 patents
- Trade Secret Choc…
Trade Secret Chocolates
7 patents
- Tradecapture OTC
Tradecapture OTC Corp.
7 patents
- Trajan Scientific…
Trajan Scientific Australia Pty Ltd
7 patents
- Tramontina USA
Tramontina USA, Inc.
7 patents
- Tracon Pharmaceut… ◀
Tracon Pharmaceuticals, Inc.
7 patents
What this shows Tracon holds 7 patents at rank #38,009, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Tracon
By rank, the assignees closest to #38,009 in granted patent volume.
- Touchfire, Inc. #38,005 · 7 patents
- Touchlight IP Limited #38,006 · 7 patents
- Touchstone Research Laboratory Ltd. #38,007 · 7 patents
- Toyko Electron Limited #38,008 · 7 patents
- Trade Secret Chocolates #38,010 · 7 patents
- Tradecapture OTC Corp. #38,011 · 7 patents
- Trajan Scientific Australia Pty Ltd #38,012 · 7 patents
- Tramontina USA, Inc. #38,013 · 7 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in Tracon's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Tracon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 29th percentile higher than 29% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 14.3% |
| 2016 | 1 | 14.3% |
| 2018 | 3 | 42.9% |
| 2019 | 2 | 28.6% |
Which technologies does Tracon Pharmaceuticals, Inc. patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Tracon Pharmaceuticals, Inc.'s patent record in context - here's where to go next.
- Tracon Pharmaceuticals, Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #38,008 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Tracon Pharmaceuticals, Inc. against Touchfire, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 28.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.